share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle

SEC announcement ·  Apr 16 16:16
Summary by Moomoo AI
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 13 shares of common stock on April 15, 2024. The transaction was carried out directly with the shares acquired at a price of $750.77 each. Following this transaction, Sulzberger's direct holdings in the company increased to a total of 2,128 shares. The acquisition reflects a transaction value of approximately $9,760.01, based on the purchase price. This transaction was classified as a grant, award, or other acquisition, as per the transaction code description provided.
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of 13 shares of common stock on April 15, 2024. The transaction was carried out directly with the shares acquired at a price of $750.77 each. Following this transaction, Sulzberger's direct holdings in the company increased to a total of 2,128 shares. The acquisition reflects a transaction value of approximately $9,760.01, based on the purchase price. This transaction was classified as a grant, award, or other acquisition, as per the transaction code description provided.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more